Cargando…
Effect of Human Flavin-Containing Monooxygenase 3 Polymorphism on the Metabolism of Aurora Kinase Inhibitors
Aurora kinases were recently identified as a potential target in anticancer therapy and, amongst their available inhibitors, Tozasertib (VX-680) and Danusertib (PHA-739358) have been indicated as possible substrates of human flavin-containing monooxygenase 3 (hFMO3). Here we report the in vitro rate...
Autores principales: | Catucci, Gianluca, Occhipinti, Andrea, Maffei, Massimo, Gilardi, Gianfranco, Sadeghi, Sheila J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3588010/ https://www.ncbi.nlm.nih.gov/pubmed/23358255 http://dx.doi.org/10.3390/ijms14022707 |
Ejemplares similares
-
Flavin-Containing Monooxygenases Are Conserved Regulators of Stress Resistance and Metabolism
por: Huang, Shijiao, et al.
Publicado: (2021) -
Metabolic Regulation of Longevity by One-Carbon Metabolism and Flavin-Containing Monooxygenase
por: Choi, Christopher, et al.
Publicado: (2020) -
Evolution of enzyme functionality in the flavin-containing monooxygenases
por: Bailleul, Gautier, et al.
Publicado: (2023) -
Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017) -
Production of drug metabolites by human FMO3 in Escherichia coli
por: Catucci, Gianluca, et al.
Publicado: (2020)